Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1545-1552

  Batrakova, E V ^a,c   Dorodnych, T Y ^a,b   Klinskii, E Y ^a,d   Kliushnenkova, E N ^a   Shemchukova, O B ^a   Goncharova, O N ^a   Arjakov, S A ^b   Alakhov, V Y ^a,d   Kabanov, A V ^a,c  

^a Russ Res Ctr Molec D   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Block copolymer; Doxorubicin; Drug resistance; Epirubicin; Pluronic

Indexed keywords

ANTHRACYCLINE; ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; EPIRUBICIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; HYDROPHOBICITY; LEUKEMIA P 388; LIFESPAN; MICELLE; MULTIDRUG RESISTANCE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029904510     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.587     Document Type: Article

References (27)

1. ALAKHOV V YU, BATRAKOVA EV, DORODNICH T, LI S, VENNE A AND KABANOV AV. (1996a). Block copolymeric drug carriers: 1. delivery of antineoplstic drugs. In Abstracts of First International Symposium on Polymer Therapeutics. p. 213. The School of Pharmacy, University of London: London, UK.
2. ALAKHOV V YU, MOSKALEVA E YU, BATRAKOVA EV AND KABANOV AV. (1996b). Reversion of multidrug resistance of human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconj. Chem., 7, 209-216.
3. ALEXANDRIS P, HOLZWARTH JF AND HATTON TA. (1994). Micellization of poly(ethylene oxide)-poly(propylene oxide) triblock copolymers in aqueous solutions: thermodynamcis of copolymer association. Macromeolecules, 27, 2414-2425.
4. BADER H, RINGSDORF H AND SCHMIDT B. (1984). Water soluble polymers in medicine. Angew. Makromol. Chemie., 123/124, 457-483.
5. DEXTER DL, HESSON DP, ARDECKY RJ, RAO GV, TIPPETT DL, DUSAK BA, PAULL KD, PLOWMAN J, DELARCO BM, NARAYANAN VL AND FORBES M. (1985). Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4- quinolinecarboxylic acid sodium salt], against experimental tumors. Cancer Res., 45, 5563-5568.
6. DOUGHTY JC, ANDERSON JH, WILLMOTT N AND MCARDLE CS. (1995). Intra-arterial administration of adriamycin-loaded albumin microspheres for locally advanced breast cancer. Postgrad. Med. J., 71, 47-49.
7. DRAPER M, SAVAGE M, COLLET JH, ATTWOOD D, PRICE C, BOOTH C AND WANG Q-G. (1995). Solubilization of drugs in micellar systems studied by eluent gel permeation chromatography. Pharm. Res., 12, 1231-1237.
8. DUNCAN R. (1992). Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs, 3, 175-210.
9. DUNN SE, BRINDLEY A, DAVIS SS, DAVIES MC AND ILLUM L. (1994). Polystyrene-poly(ethylene glycol) (PS-PEG20000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm. Res., 11, 1016-1022.
10. FERRARI M, FORNASIERO MC AND ISETTA AM. (1990). MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J. Immunol. Methods, 131, 165-172.
11. GABIZON A. (1993). Tailoring liposomes for cancer drug delivery: from the bench to the clinic. Ann. Biol. Clin. Paris, 51, 811-813.
12. GOLDIN A, VENDITTI JM, MACDONALD JS, MUGGIA FM, HENNEY JE AND DEVITA JR VT. (1981). Current results of the screening program at the division of cancer treatment, National Cancer Institute. Eur. J. Cancer, 17, 129-142.
13. KABANOV AV, CHEKHONIN VP, ALAKHOV V YU, BATRAKOVA EV, LEBEDEV AS, MELIK-NUBAROV NS, ARZHAKOV SA, LEVASHOV AV, MOROZOV GV, SEVERIN ES AND KABANOV VA. (1989). The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett., 258, 343-345.
14. KABANOV AV, BATRAKOVA EV, MELIK-NUBAROV NS, FEDOSEEV NA, DORODNICH T YU, ALAKHOV V YU, CHEKHONIN VP, NAZAROVA IR AND KABANOV VA. (1992). A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J. Contr. Release, 22, 141-158.
15. KABANOV AV, NAZAROVA IR, ASTAFIEVA IV, BATRAKOVA EV, ALAKHOV V YU, YAROSLAVOV AA AND KABANOV VA. (1995). Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions. Macromolecules, 28, 2303-2314.
16. KWON G, NAITO M, YOKOYAMA M, OKANO T, SAKURAI Y AND KATAOKA K. (1993). Micelles based on AB block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate). Langmuir, 9, 945-949.
17. KWON GS, NAITO M, YOKOYAMA M, OKANO T, SAKURAI Y AND KATAOKA K. (1995). Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res., 12, 192-195.
18. LA SB, OKANO T AND KATAOKA K. (1996). Preparation and characterization of the micelie-forming polymeric drug. Indomethacin-incorporated poly(ethylene oxide)-poly(b-benzyl L-aspartate) block copolymer micelles. J. Pharm. Science, 85, 85-90.
19. MAEDA H, SEYMOUR LW AND MIYAMOTO Y. (1992). Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconj. Chem., 3, 351-362.
20. MAYER LD, MASIN D, NAYAR R, BOMAN NL AND BALLY MB. (1995). Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumors. Br. J. Cancer, 71, 482-488.
21. REILLY RM, SANDHU J, ALVARES-DIEZ TM, GALLINGER S, KIRSH J AND STERN H. (1995). Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin. Pharmacokin., 28, 126-142.
22. SHIMOMURA K, MANDA T, MAKUMOTO S, MASUDA K, NAKAMURA T, MIZOTA T, MATSUMOTO S, NISHIGAKI F, OKU T, MORI J AND SHIBAYAMA F. (1988). Antitumor activity and hematoxicity of a new, substituted dihydrobenzoxazine FK973, in mice. Cancer Res., 48, 1166-1172.
23. SUBR V, STROHALM J, ULBRICH K, DUNCAN R AND HUME IC. (1992). Polymers containing enzymatically degradable bonds. XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly[N-(2-hydroxypropyl)-methacrylamide] copolymer drug carriers in vitro and antitumor activity measured in vivo. J. Contr. Rel., 18, 123-132.
24. TORCHILIN VP, OMELYANENKO VG, PAPISOV MI, BOGDANOV AA JR, TRUBETSKOY VS, HERRON JN AND GENTRY CA. (1994). Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta, 1195, 11-20.
25. TRUBETSKOY VS, TORCHILIN VP, GAZELLE GS AND WOLF GL. (1994). Amphiphilic radiopaque iodine-containing block-copolymer as micellar polymeric carrier with controlled in vivo performance. Proc. Intern. Symp. Control. Rel. Bioact. Mat., 21, 676-677.
26. YOKOYAMA M, MIYAUCHI M, YAMADA N, OKANO T, SAKURAI, Y, KATAOKA K AND INQUE S. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res., 50, 1693-1700.
27. YOKOYAMA M, OKANO T, SAKURAI Y, EKIMOTO H, SHIBAZAKI C AND KATAOKA K. (1991). Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res., 51, 3229-3236.